Colifoam (hydrocortisone acetate rectal foam): Supply issue
Hydrocortisone acetate rectal foam (Colifoam) has been out of stock since early 2019. We are advised that resupply is expected in the first quarter of 2022.
15 July 2022: Resupply date updated
Resupply: first quarter 2023
The supplier advises that the Colifoam will likely be resupplied during the first quarter of 2023.
Alternative product: Cortifoam
Mylan have sourced a hydrocortisone product from the US, called Cortifoam (pharmacode 2608707).
This was listed in the Schedule from 1 June 2021.
Cortifoam is not Medsafe-approved. It must be prescribed and supplied under section 29 of the Medicines Act.
Clinect had previously sourced an alternative agent, prednisolone sodium – rectal foam 20 mg per dose (brand name: Essential Prednisolone). This was listed in the Pharmaceutical Schedule on 1 October 2020.
Essential Prednisolone is not approved for use in New Zealand by Medsafe. It must be supplied under section 29 of the Medicines Act. We apologise for any inconvenience this causes.